XML 23 R9.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Common stock
Common stock
Class B common stock
Additional paid-in capital
Treasury stock
Retained earnings (deficit)
Retained earnings (deficit)
Cumulative Effect, Period of Adoption, Adjustment
Accumulated other comprehensive income (loss)
Non-redeemable non-controlling interest
Beginning balance (in shares) at Dec. 31, 2018     231,492,986 12,799,999   97,158,586        
Beginning balance at Dec. 31, 2018 $ 5,651 $ 6 $ 0 $ 0 $ 9,549 $ (5,742) $ 517 $ 6 $ (220) $ 1,547
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) 87           80     7
Other comprehensive income (loss), net of taxes 2               4 (2)
Payment of dividends to common stockholders (95)           (95)      
Proceeds from exercise of equity instruments and employee stock purchase plans (in shares)     2,609,200              
Proceeds from exercise of equity instruments and employee stock purchase plans 156       156          
Withholding taxes for stock options (2)       (2)          
Treasury stock activity related to vesting of equity instruments (in shares)           225,626        
Treasury stock activity related to vesting of equity instruments (29)         $ (29)        
Other changes in ownership of non-controlling interests 10       (3)         13
Stock-based compensation expense 119       119          
Other 2       2          
Ending balance (in shares) at Jun. 30, 2019     234,102,186 12,799,999   97,384,212        
Ending balance at Jun. 30, 2019 5,907   $ 0 $ 0 9,821 $ (5,771) 508   (216) 1,565
Beginning balance (in shares) at Mar. 31, 2019     233,294,034 12,799,999   97,355,708        
Beginning balance at Mar. 31, 2019 5,634   $ 0 $ 0 9,694 $ (5,767) 373   (217) 1,551
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) 187           183     4
Other comprehensive income (loss), net of taxes 7               1 6
Payment of dividends to common stockholders (48)           (48)      
Proceeds from exercise of equity instruments and employee stock purchase plans (in shares)     808,152              
Proceeds from exercise of equity instruments and employee stock purchase plans 65       65          
Withholding taxes for stock options (2)       (2)          
Treasury stock activity related to vesting of equity instruments (in shares)           28,504        
Treasury stock activity related to vesting of equity instruments (4)         $ (4)        
Other changes in ownership of non-controlling interests 4                 4
Stock-based compensation expense 63       63          
Other 1       1          
Ending balance (in shares) at Jun. 30, 2019     234,102,186 12,799,999   97,384,212        
Ending balance at Jun. 30, 2019 5,907   $ 0 $ 0 9,821 $ (5,771) 508   (216) 1,565
Beginning balance (in shares) at Dec. 31, 2019     256,691,777 12,799,999   126,892,525        
Beginning balance at Dec. 31, 2019 5,536   $ 0 $ 0 12,978 $ (9,673) 879   (217) 1,569
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) (2,137)           (2,037)     (100)
Other comprehensive income (loss), net of taxes (56)               (56)  
Payment of dividends to common stockholders (48)           (48)      
Proceeds from exercise of equity instruments and employee stock purchase plans (in shares)     2,393,155              
Proceeds from exercise of equity instruments and employee stock purchase plans 96       96          
Treasury stock activity related to vesting of equity instruments (in shares)           393,099        
Treasury stock activity related to vesting of equity instruments (44)         $ (44)        
Other changes in ownership of non-controlling interests 10       10          
Stock-based compensation expense 118       118          
Other 1       1          
Other (in shares)           20,630        
Common stock warrants, net of issuance costs $ 110       110          
Common stock repurchases (in shares) 3,400,000         3,364,119        
Common stock repurchases $ (370)         $ (370)        
Payment of preferred dividends (17)       (17)          
Adjustment to the fair value of redeemable non-controlling interests 4       4          
Ending balance (in shares) at Jun. 30, 2020     259,084,932 12,799,999   130,670,373        
Ending balance at Jun. 30, 2020 3,203   $ 0 $ 0 13,300 $ (10,087) (1,206)   (273) 1,469
Beginning balance (in shares) at Mar. 31, 2020     258,769,812 12,799,999   130,592,112        
Beginning balance at Mar. 31, 2020 3,741   $ 0 $ 0 13,124 $ (10,083) (470)   (301) 1,471
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) (740)           (736)     (4)
Other comprehensive income (loss), net of taxes 34               28 6
Proceeds from exercise of equity instruments and employee stock purchase plans (in shares)     315,120              
Proceeds from exercise of equity instruments and employee stock purchase plans 10       10          
Treasury stock activity related to vesting of equity instruments (in shares)           57,631        
Treasury stock activity related to vesting of equity instruments (4)         $ (4)        
Other changes in ownership of non-controlling interests 5       9         (4)
Stock-based compensation expense 59       59          
Other 1       1          
Other (in shares)           20,630        
Common stock warrants, net of issuance costs 110       110          
Payment of preferred dividends (17)       (17)          
Adjustment to the fair value of redeemable non-controlling interests 4       4          
Ending balance (in shares) at Jun. 30, 2020     259,084,932 12,799,999   130,670,373        
Ending balance at Jun. 30, 2020 $ 3,203   $ 0 $ 0 $ 13,300 $ (10,087) $ (1,206)   $ (273) $ 1,469